NICE urgent cancer referral guidance (guidelines with respect to primary care investigations)
FREE subscriptions for doctors and students... click here
You have 3 more open access pages.
This part of the database outlines NICE urgent cancer referral guidance with respect to possible investigations (and results from these) undertaken in primary care.
Reference:
Last reviewed 06/2021
Links:
- NICE urgent cancer referral guidance
- NICE urgent cancer referral guidance (guidelines with respect to presenting symptoms and signs)
- anaemia - NICE urgent cancer referral guidance
- blood glucose levels - NICE urgent cancer referral guidance
- hypercalcaemia or leukopenia and presentation consistent with possible myeloma, 60 and over - NICE urgent cancer referral guidance
- plasma viscosity (PV) or erythrocyte sedimentation rate (ESR) and presentation consistent with possible myeloma - NICE urgent cancer referral guidance
- PSA (NICE urgent referral guidance for suspected cancer)
- protein electrophoresis suggests myeloma - NICE urgent cancer referral guidance
- Ca125 (Ca - 125) - NICE urgent cancer referral guidance
- raised platelet count (thrombocytosis) - NICE urgent cancer referral guidance
- raised white cell count - NICE urgent cancer referral guidance
- NICE guidance - use of faecal occult blood (FOB) testing to identify possible colorectal cancer